Reuters: Money News: Sun Pharma slumps after $550 mln patent suit settlement with Pfizer

Reuters: Money News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Sun Pharma slumps after $550 mln patent suit settlement with Pfizer Jun 13th 2013, 03:55 MUMBAI (Reuters) - Shares in Sun Pharmaceutical Industries more than 5 percent after the company settled a patent suit with Pfizer Inc related to its acid-reflux drug for $550 million.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions